WHO ICTRP trial
Effect of Shampakadi Kwatha in the management of Vatrakta w.s.r to Hyperuricemia
CTRI/2023/01/049163 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/01/049163 |
|---|---|
| Public title | Effect of Shampakadi Kwatha in the management of Vatrakta w.s.r to Hyperuricemia |
| Scientific title | A clinical study to evaluate the effect of Shampakadi Kwatha in the management of Vatrakta w.s.r. to Hyperuricemia |
| Primary sponsor | Principal |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases Health Condition 2: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease |
| Registration date | Jan 24, 2023 |
| Target size | 30 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: